Healthcare News & Insights

New test for Alzheimer’s may be on the way

A new type of brain scan could give doctors their first chance to prove Alzheimer’s diagnoses while patients are alive.

Avid Radiopharmaceuticals, a Philadelphia-based company has developed a dye that allows doctors to see the plaques forming in the brains of Alzheimer’s patients.

The research will be presented next month at the Alzheimer’s Association international meeting. And the test still has to be approved by the FDA.

But if it makes it through that process, it’ll be the first test that allows doctors to confirm an Alzheimer’s diagnoses without a postmortem brain biopsy. (Currently, 20% of dementia patients diagnosed with Alzheimer’s have been found to not have the disease after the brain biopsy is performed.)

It’ll also provide researchers with better information on the effectiveness of drugs and other therapies used to treat the disease.

Subscribe Today

Get the latest and greatest healthcare news and insights delivered to your inbox.